AKR1C1 and neoplasm: This allowed us to unravel hallmark gene signatures of the tumor-normal ecosystems, outline distinctions between AKR1C1+ and WNT5A+ inflammatory fibroblasts, and characterize TLS-enriched and non-enriched cell types among immunotherapy-favorable components.